Form 4: Acadia Healthcare Director Patrice A. Harris Reports Acquisition of 7,032 Shares Through Compensatory Grant

Acadia Healthcare Company, Inc. Director Patrice A. Harris reported the acquisition of 7,032 shares of common stock on May 29, 2025, as part of a compensatory grant with a three-year vesting schedule.

Summary

• Patrice A. Harris, a Director of Acadia Healthcare Company, Inc. (ACHC), acquired 7,032 shares of common stock.
• The transaction occurred on May 29, 2025.
• The shares were acquired at a price of $0, indicating a compensatory grant rather than a direct purchase.
• These granted shares will vest over a 3-year period in equal yearly installments, with the vesting commencing on May 29, 2026.
• Following this transaction, Ms. Harris beneficially owns a total of 11,583 shares of Acadia Healthcare common stock.

Sentiment

Score: 7

Explanation: The filing reports a routine compensatory stock grant to a director, which is a positive sign of alignment between management and shareholder interests, and a standard practice for executive retention and incentive. It does not indicate any negative operational or financial news.

Positives

• Director Patrice A. Harris received a grant of 7,032 shares of common stock, which aligns her interests with long-term shareholder value.
• The grant at a $0 price signifies a compensatory award, a common practice used to incentivize and retain key personnel within the company.

Risks

• The value of the granted shares is subject to the future performance of Acadia Healthcare's stock price.
• The shares are not immediately owned outright by the director due to the 3-year vesting schedule, meaning full ownership is contingent on continued service and time.

Future Outlook

The compensatory stock grant with a multi-year vesting schedule indicates a commitment to retaining the director and aligning her incentives with the company's long-term performance and strategic goals.

Industry Context

This Form 4 filing reports a routine compensatory equity grant to a director, which is a standard practice across publicly traded companies in various sectors, including healthcare. Such grants are a common component of executive and director compensation packages designed to align their interests with long-term shareholder value.

Comparison to Industry Standards

• Compensatory stock grants are a standard practice for director compensation across publicly traded companies, including those in the healthcare sector.
• The specific size of the grant (7,032 shares) and the 3-year vesting schedule are typical for such awards, consistent with common practices observed in peer companies like Universal Health Services (UHS), Community Health Systems (CYH), or HCA Healthcare (HCA) in terms of director compensation structures.

Related Party Transactions

• The acquisition of shares by a director from the company constitutes a related party transaction, specifically a compensatory equity grant, which is a standard form of director remuneration.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The 7,032 shares granted to Patrice A. Harris will vest over a 3-year period in equal yearly installments, beginning on May 29, 2026.

Key Dates

Recommendation

Keywords

Acadia Healthcare, ACHC, Form 4, Insider Transaction, Stock Grant, Director Compensation, Equity Award, Beneficial Ownership, Patrice A. Harris